SCHEMBL6517246

SCHEMBL6517246

CCCC1CCCC(C)(C)C1C

nearest known ligand 0.42

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA4 P22748 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6517249 1.00 CA1 (0.42) CA1CA2CA4
SCHEMBL6517247 1.00 CA1 (0.42) CA1CA2CA4
SCHEMBL907554 1.00 CA1 (0.42) CA1CA2CA4
SCHEMBL672248 0.78 ALDH1A1 (0.31)
SCHEMBL14099603 0.72 NOS1 (0.32) CA1CA2CA4
SCHEMBL11591596 0.69 CA1 (0.67) CA1CA2CA4
SCHEMBL17063633 0.69 CA1 (0.59) CA1CA2CA4
SCHEMBL18813658 0.69 L3MBTL1 (0.31)
SCHEMBL3439389 0.67 CA1 (0.32) CA1CA2CA4
SCHEMBL3439393 0.67 CA1 (0.32) CA1CA2CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1556019-A2 COMBINATION THERAPY USING 1-AMINOCYCLOHEXANE DERIVATIVES AND ACETYLCHOLINESTERASE INHIBITORS Merz Pharma GmbH & Co. KGaA (DE) 2005-07-27 EP disclosed
WO-2004037234-A2 COMBINATION THERAPY USING 1-AMINOCYCLOHEXANE DERIVATIVES AND ACETYLCHOLINESTERASE INHIBITORS MERZ PHARMA GMBH & CO. KGAA (DE) 2004-05-06 WO disclosed